Literature DB >> 18402833

Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.

Susanne W M van den Borne1, Jack P M Cleutjens, Roeland Hanemaaijer, Esther E Creemers, Jos F M Smits, Mat J A P Daemen, W Matthijs Blankesteijn.   

Abstract

BACKGROUND: Infarct rupture is a usually fatal complication of myocardial infarction (MI), for which no molecular mechanism has been described in humans. Experimental evidence in mouse models suggests that the degradation of the extracellular matrix by matrix metalloproteinases (MMPs) plays an important role in infarct rupture. The present study was designed to study the role of MMP-2, MMP-8, and MMP-9 in human infarct rupture.
METHODS: Heart samples were obtained from patients who died from infarct rupture and control MI patients. The MMP activity was determined by zymography and quantitative immunocapture activity assay. TIMP-1 levels were measured and immunohistochemistry for MMP-2 and MMP-9 was performed.
RESULTS: The amounts of both total and active MMP-8 and MMP-9 were significantly higher in ruptured infarct tissue than in control MI tissue, but no differences in MMP-2 activity were observed. Furthermore, the number of inflammatory cells was significantly higher in the ruptured infarcts than in control infarcts.
CONCLUSIONS: These data suggest that increased MMP-8 and MMP-9 activity in the infarct area, caused by a more prominent infiltration of inflammatory cells, contribute to infarct rupture in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402833     DOI: 10.1016/j.carpath.2007.12.012

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  44 in total

1.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice.

Authors:  Tibor Kempf; Alexander Zarbock; Christian Widera; Stefan Butz; Anika Stadtmann; Jan Rossaint; Matteo Bolomini-Vittori; Mortimer Korf-Klingebiel; L Christian Napp; Birte Hansen; Anna Kanwischer; Udo Bavendiek; Gernot Beutel; Martin Hapke; Martin G Sauer; Carlo Laudanna; Nancy Hogg; Dietmar Vestweber; Kai C Wollert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.

Authors:  Merry L Lindsey; Andriy Yabluchanskiy; Yonggang Ma
Journal:  Cardiology       Date:  2015-08-01       Impact factor: 1.869

Review 4.  Image-guided therapies for myocardial repair: concepts and practical implementation.

Authors:  Frank M Bengel; Richard T George; Karl H Schuleri; Albert C Lardo; Kai C Wollert
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-05-29       Impact factor: 6.875

Review 5.  Proteasome inhibitors and cardiac cell growth.

Authors:  Nadia Hedhli; Christophe Depre
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

6.  Expression of ADAM-15 in rat myocardial infarction.

Authors:  Ji Ke Li; Wen Juan Du; Shu Lin Jiang; Hai Tian
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 7.  Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages.

Authors:  Hisahito Shinagawa; Stefan Frantz
Journal:  Curr Heart Fail Rep       Date:  2015-06

8.  Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.

Authors:  Vijay Kandalam; Ratnadeep Basu; Thomas Abraham; Xiuhua Wang; Ahmed Awad; Wei Wang; Gary D Lopaschuk; Nobuyo Maeda; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

9.  Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis.

Authors:  Tamara Djurić; Maja Zivković; Aleksandra Stanković; Ana Kolaković; Djole Jekić; Vesna Selaković; Dragan Alavantić
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 10.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.